Dr. Chen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
280 Exempla Cir
Lafayette, CO 80026Phone+1 303-673-1635Fax+1 303-673-1865
Education & Training
University of Pennsylvania Health SystemResidency, Radiation Oncology, 1998 - 2003
Flushing Hospital Medical CenterInternship, Transitional Year, 1997 - 1998
Hunan Medical UniversityClass of 1984
Certifications & Licensure
CO State Medical License 2003 - 2025
MI State Medical License 2017 - 2022
OH State Medical License 2012 - 2021
PA State Medical License 1999 - 2004
NJ State Medical License 2002 - 2003
American Board of Radiology Radiation Oncology
Clinical Trials
- A Phase I Dose Escalation Study of Vandetanib (ZactimaTM , ZD6474) With Hypofractionated Stereotactic Radiotherapy in Patients With Recurrent Malignant Gliomas Start of enrollment: 2007 Jan 01
- A Dose Per Fraction Escalation Trial of Hypofractionated IMRT With Temozolomide for Newly Diagnosed Glioblastoma Start of enrollment: 2005 Nov 01
- Dose Escalation Study of Vandetanib With Hypofractionated Stereotactic Radiotherapy in Recurrent Malignant Gliomas Start of enrollment: 2007 Mar 01
Publications & Presentations
PubMed
- 16 citationsPhase I study of vandetanib with radiation therapy with or without cisplatin in locally advanced head and neck squamous cell carcinoma.Vasiliki A. Papadimitrakopoulou, Steven J. Frank, Ezra W.E. Cohen, Fred R. Hirsch, Jeffrey N. Myers
Head & Neck. 2016-03-01 - 20 citationsDetermination of optimal PTV margin for patients receiving CBCT-guided prostate IMRT: comparative analysis based on CBCT dose calculation with four different marginsSukhdeep K. Gill, Krishna Reddy, Nina Campbell, Changhu Chen, D Pearson
Journal of Applied Clinical Medical Physics. 2015-11-08 - 23 citationsHypofractionated-intensity modulated radiotherapy (hypo-IMRT) and temozolomide (TMZ) with or without bevacizumab (BEV) for newly diagnosed glioblastoma multiforme (GBM...Julie A. Carlson, Krishna Reddy, Laurie E. Gaspar, Douglas E. Ney, Brian D. Kavanagh
Journal of Neuro-Oncology. 2015-04-29
Press Mentions
Alternative Cancer Treatment Helps Oregon WomanJanuary 16th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
